CS130592A3 - 3-/indole-2-carboxamido/quinuclidine, process for preparing thereof and apharmaceutical composition which contains it - Google Patents
3-/indole-2-carboxamido/quinuclidine, process for preparing thereof and apharmaceutical composition which contains itInfo
- Publication number
- CS130592A3 CS130592A3 CS921305A CS130592A CS130592A3 CS 130592 A3 CS130592 A3 CS 130592A3 CS 921305 A CS921305 A CS 921305A CS 130592 A CS130592 A CS 130592A CS 130592 A3 CS130592 A3 CS 130592A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- quinuclidine
- carboxamido
- indole
- preparing
- apharmaceutical composition
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical compound C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4115215A DE4115215A1 (de) | 1991-05-10 | 1991-05-10 | Indolderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS130592A3 true CS130592A3 (en) | 1992-11-18 |
Family
ID=6431344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS921305A CS130592A3 (en) | 1991-05-10 | 1992-04-29 | 3-/indole-2-carboxamido/quinuclidine, process for preparing thereof and apharmaceutical composition which contains it |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0512350A3 (enExample) |
| JP (1) | JPH05155886A (enExample) |
| KR (1) | KR920021507A (enExample) |
| AU (1) | AU1604492A (enExample) |
| CA (1) | CA2068238A1 (enExample) |
| CS (1) | CS130592A3 (enExample) |
| DE (1) | DE4115215A1 (enExample) |
| HU (1) | HU208136B (enExample) |
| IE (1) | IE921488A1 (enExample) |
| MX (1) | MX9202152A (enExample) |
| NO (1) | NO921831L (enExample) |
| PL (1) | PL294457A2 (enExample) |
| TW (1) | TW221807B (enExample) |
| ZA (1) | ZA923351B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69111816T4 (de) * | 1990-08-31 | 1996-08-01 | Nippon Shinyaku Co Ltd | Indolederivate und ihre verwendung als serotonin-antagoniste. |
| IT1255467B (it) * | 1992-07-29 | 1995-11-02 | Dompe Farmaceutici Spa | Ammidi acriliche farmacologicamente attive |
| US6492385B2 (en) | 2000-08-18 | 2002-12-10 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease |
| AU2001282874A1 (en) | 2000-08-18 | 2002-03-04 | Pharmacia And Upjohn Company | Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| US6486172B2 (en) | 2000-08-18 | 2002-11-26 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
| WO2002017358A2 (en) | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists) |
| WO2002015662A2 (en) | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists |
| DE10045112A1 (de) * | 2000-09-11 | 2002-03-21 | Merck Patent Gmbh | Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems |
| AR036041A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen |
| AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
| CZ2004408A3 (cs) | 2001-10-02 | 2005-03-16 | Pharmacia & Upjohn Company | Azabicyklicky substituované kondenzované heteroarylsloučeniny |
| US6849620B2 (en) | 2001-10-26 | 2005-02-01 | Pfizer Inc | N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| CA2476624A1 (en) | 2002-02-19 | 2003-08-28 | Pharmacia & Upjohn Company | Azabicyclic compounds for the treatment of disease |
| JP2005523288A (ja) | 2002-02-19 | 2005-08-04 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 疾病治療用の縮合した二環式−ｎ−架橋−複素環式芳香族カルボキサミド |
| WO2004013137A1 (en) | 2002-08-01 | 2004-02-12 | Pharmacia & Upjohn Company Llc | 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity |
| WO2009158375A1 (en) * | 2008-06-25 | 2009-12-30 | Abbott Laboratories | Aza-cylic indole- 2 -carboxamides and methods of use thereof |
| HUE026815T2 (en) | 2008-11-19 | 2016-07-28 | Forum Pharmaceuticals Inc | Treatment of Cognitive Disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof |
| TWI519532B (zh) | 2010-05-17 | 2016-02-01 | 艾維沃製藥公司 | （Ｒ）－７－氯－Ｎ－（啶－３－基）苯並［b］噻吩－２－羧醯胺鹽酸鹽單水合物之結晶形體 |
| RU2017136693A (ru) | 2012-05-08 | 2019-02-08 | Форум Фармасьютикалз, Инк. | Способы поддержания, лечения или улучшения когнитивной функции |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU202108B (en) * | 1986-07-30 | 1991-02-28 | Sandoz Ag | Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol |
| DE3881950T2 (de) * | 1987-04-25 | 1993-09-30 | Beecham Group Plc | Azabicyclische Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. |
| NZ227841A (en) * | 1988-02-12 | 1991-08-27 | Merck Sharp & Dohme | Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions |
| DE3810552A1 (de) * | 1988-03-29 | 1989-10-19 | Sandoz Ag | Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben |
-
1991
- 1991-05-10 DE DE4115215A patent/DE4115215A1/de not_active Withdrawn
-
1992
- 1992-04-27 EP EP19920107132 patent/EP0512350A3/de not_active Withdrawn
- 1992-04-29 CS CS921305A patent/CS130592A3/cs unknown
- 1992-05-05 AU AU16044/92A patent/AU1604492A/en not_active Abandoned
- 1992-05-07 PL PL29445792A patent/PL294457A2/xx unknown
- 1992-05-07 TW TW081103571A patent/TW221807B/zh active
- 1992-05-08 KR KR1019920007824A patent/KR920021507A/ko not_active Withdrawn
- 1992-05-08 MX MX9202152A patent/MX9202152A/es unknown
- 1992-05-08 NO NO92921831A patent/NO921831L/no unknown
- 1992-05-08 ZA ZA923351A patent/ZA923351B/xx unknown
- 1992-05-08 HU HU9201550A patent/HU208136B/hu not_active IP Right Cessation
- 1992-05-08 CA CA002068238A patent/CA2068238A1/en not_active Abandoned
- 1992-05-11 JP JP4143642A patent/JPH05155886A/ja active Pending
- 1992-07-01 IE IE148892A patent/IE921488A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT61541A (en) | 1993-01-28 |
| KR920021507A (ko) | 1992-12-18 |
| CA2068238A1 (en) | 1992-11-11 |
| PL294457A2 (en) | 1992-11-16 |
| HU9201550D0 (en) | 1992-07-28 |
| IE921488A1 (en) | 1992-11-18 |
| EP0512350A2 (de) | 1992-11-11 |
| NO921831D0 (no) | 1992-05-08 |
| MX9202152A (es) | 1992-11-01 |
| HU208136B (en) | 1993-08-30 |
| DE4115215A1 (de) | 1992-11-12 |
| ZA923351B (en) | 1993-01-27 |
| TW221807B (enExample) | 1994-03-21 |
| AU1604492A (en) | 1992-11-12 |
| NO921831L (no) | 1992-11-11 |
| EP0512350A3 (en) | 1992-12-16 |
| JPH05155886A (ja) | 1993-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9300864D0 (en) | Method for preparing bilogically active composition | |
| PH31205A (en) | Pharmaceutical composition. | |
| HU9201975D0 (en) | Method for preparing medical compositions | |
| GB9521654D0 (en) | 1-N-Ethyl gentamicin derivatives and the method for preparing thereof | |
| HUT64734A (en) | Anthraquinone-derivativdes, process for preparing them and pharmaceutical compositions containing them | |
| HUT68416A (en) | Thermoplastic composition and process for preparing the same | |
| PH31073A (en) | Pharmaceutical composition and process for the preparation thereof. | |
| OA09810A (en) | Pharmaceutical composition. | |
| EP0435333A3 (en) | Cephalosporin derivatives, the process for preparing the same, and antimicrobial composition containing the derivatives | |
| EP0464545A3 (en) | Paste composition and method for preparing the same | |
| ZA929001B (en) | Process for preparing sintered shapes and compositions for use therein. | |
| PH27259A (en) | Solid correction composition | |
| ZA938745B (en) | Process for preparing immunoconjugates. | |
| HRP931016A2 (en) | Thienothiazin derivatives, process for the preparation and application thereof | |
| IL103142A0 (en) | Substituted aminopropanes,processes for their preparation,and their use | |
| AU8714391A (en) | Apparatus for preventing whiplash | |
| EP0621866A4 (en) | Process for preparing 3-acylestratrienes and acylbenzenes. | |
| PH31154A (en) | Process for preparing 1-alkylryl-2-alkyl-5-formyl-imidazole. | |
| IL116967A (en) | Ethyl-6-formyloxy-4-hexenoate and process for the preparation thereof | |
| IL106433A0 (en) | Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same | |
| ZA922354B (en) | Pharmaceutical composition and process for the preparation thereof | |
| ZA92505B (en) | Substituted 3-aminosydnone imines,process for the preparation therefore and the use thereof | |
| AU1355792A (en) | A pulverous composition, a method for preparing it, and a method for improving the taste of the composition | |
| LTIP606A (en) | Peptide compounds, method for the preparation and use thereof | |
| ZA915631B (en) | Process for the preparation n-alkylsulfonylaminosulfonylureas |